Advanced Technology Laboratory's HDI 3000 reduces breast biopsies
This article was originally published in Clinica
Executive Summary
The US FDA has approved Advanced Technology Laboratory's HDI 3000 ultrasound system for differentiating benign from malignant lesions when used as an adjunct to mammography. The company says that its system may reduce the number of breast biopsies by as much as 40% based on the results of an international multi-centre study.